To amend the Employee Retirement Income Security Act of 1974 to allow health marketplace pools to be deemed an employer under section 3(5) of such Act for purposes of offering a group health plan or group health insurance coverage, and for other purposes.
Summary
HR9081, introduced May 29, 2026, would allow health marketplace pools to be treated as employers under ERISA for offering group health plans. The bill is in early stage, referred to committee, with no funding authorized. Market impact is minimal until further legislative action.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9081 is an early-stage bill with no funding attached.
- 2.The bill redefines 'employer' under ERISA to include health marketplace pools.
- 3.Market impact is minimal until the bill advances through committee and floor votes.
Market Implications
No immediate market implications. The bill is in its earliest legislative stage. Investors should watch for committee hearings and markups as signals of momentum. Until then, the healthcare insurance and provider sectors remain driven by existing regulatory and competitive dynamics.
Full Analysis
On May 29, 2026, Representative Van Duyne (R-TX) introduced HR9081 in the 119th Congress. The bill proposes amending ERISA Section 3(5) to allow health marketplace pools—such as association health plans or cooperatives—to be deemed an employer for the purpose of offering group health plans or group health insurance coverage. The bill was referred to the House Committee on Education and Workforce, the first step in the legislative process.
This bill does not authorize or appropriate any federal funds. It is a regulatory change that expands the definition of 'employer' under ERISA to include health marketplace pools. The mechanism is a statutory redefinition, not a spending program. Actual market impact depends on subsequent adoption by states and market participants.
Structural winners would be entities that operate health marketplace pools, potentially including insurance brokers, associations, and technology platforms that facilitate pooling. Insurers like UnitedHealth Group could see increased enrollment volume from new group plans, but also face pricing competition. Hospital operators like HCA Healthcare ($HCA) could benefit from reduced uninsured rates if pool plans attract previously uninsured individuals. However, these effects are speculative at this early stage.
No real market data is provided for stock price movements. The competitive landscape remains unchanged until the bill advances. The legislative path requires committee hearings, markup, House floor vote, Senate consideration, and potential presidential action—a process that typically takes months to years.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Deeming health marketplace pools as employers under ERISA section 3(5) allows them to offer group health plans or group health insurance coverage.
Who must act
Health marketplace pools (e.g., association health plans, cooperatives) seeking to offer group coverage.
What happens
Expands the pool of entities that can sponsor ERISA-covered group health plans, potentially increasing the number of insured individuals and altering payer mix for hospitals.
Stock impact
HCA Healthcare operates hospitals and surgery centers. If more individuals gain insurance through pool-sponsored plans, HCA could see reduced uncompensated care and improved payer mix. However, the effect is indirect and depends on plan design and enrollment uptake.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend title XXVII of the Public Health Service Act and title 5, United States Code, to require group health plans, health insurance issuers offering group or individual health insurance coverage, and Federal Employees Health Benefits Program health benefits plans to meet certain requirements with respect to medical child support orders, and for other purposes.
HOPE with Fertility Services Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.